Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
DXQ7ED
|
||||
Drug Name |
Bis(3-bromophenyl)(4-hydroxy)thiosemicarbazone
|
||||
Synonyms |
CHEMBL1272311
|
||||
Indication | Discovery agent | Investigative | [1587926] | ||
Formula |
C14H11Br2N3OS
|
||||
Canonical SMILES |
NC(=S)N\\N=C(\\c1cccc(Br)c1)/c2ccc(O)c(Br)c2
|
||||
InChI |
InChI=1S/C14H11Br2N3OS/c15-10-3-1-2-8(6-10)13(18-19-14(17)21)9-4-5-12(20)11(16)7-9/h1-7,20H,(H3,17,19,21)/b18-13-
|
||||
InChIKey |
UIMSYLGHIQKPJZ-AQTBWJFISA-N
|
||||
Target and Pathway | |||||
Target(s) | Cathepsin L | Target Info | [1587926] | ||
Cathepsin B | Target Info | [1587926] | |||
Reactome | Endosomal/Vacuolar pathway | ||||
Collagen degradation | |||||
Degradation of the extracellular matrix | |||||
Trafficking and processing of endosomal TLR | |||||
Assembly of collagen fibrils and other multimeric structures | |||||
MHC class II antigen presentationR-HSA-1442490:Collagen degradation | |||||
MHC class II antigen presentation | |||||
WikiPathways | Primary Focal Segmental Glomerulosclerosis FSGS | ||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.